Radiopharm Theranostics Limited (RADX)

NASDAQ: RADX · Real-Time Price · USD

1.110

-0.040 (-3.48%)

At close: Oct 8, 2026, 4:00 PM EDT

1.000

-0.110 (-9.91%)

Pre-market: Oct 9, 2026, 5:17 AM EDT

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
The Research, Development and Commercialisation of Health Technologies	12.87M	13.00M	1.59M	6.21M	8.83K
Total	12.87M	13.00M	1.59M	6.21M	8.83K

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
United States	2.77M	3.63M	299.23K	292.36K	-
Australia	-	-	-	-	8.83K
Total	2.77M	3.63M	299.23K	292.36K	8.83K